Table 3.
Comparison of patient-specific eradication rate
| EPZ |
VPZ |
p value | |
|---|---|---|---|
| eradication rate (n) | eradication rate (n) | ||
| Age, years | |||
| >70 | 84.0 (89/106) | 87.1 (108/124) | 0.499 |
| <70 | 78.5 (252/321) | 85.4 (269/315) | 0.024 |
| Gender | |||
| Male | 82.8 (197/238) | 85.4 (187/219) | 0.446 |
| Female | 76.2 (144/189) | 86.4 (190/220) | 0.008 |
| BMI | |||
| >25 | 82.0 (73/89) | 86.4 (89/103) | 0.404 |
| <25 | 79.5 (263/331) | 85.5 (283/331) | 0.041 |
| Alcohol | |||
| Yes | 79.6 (176/221) | 85.8 (188/219) | 0.085 |
| No | 80.0 (164/205) | 85.6 (184/215) | 0.129 |
| Smoking | |||
| Yes | 77.2 (44/57) | 88.1 (74/84) | 0.086 |
| No | 80.2 (296/369) | 85.1 (298/350) | 0.081 |
BMI, body mass index; EPZ, esomeprazole; VPZ, vonoprazan.